
Kathleen Moore, MD, MS, Stephenson Cancer Center
Advertisement

Kathleen N. Moore, MD, MS, is an associate director of clinical research at the Stephenson Cancer Center, the director of the Oklahoma TSET Phase I Program, and a professor in the Section of Gynecologic Oncology at Oklahoma University (OU) College of Medicine, OU Health.
Articles by Kathleen Moore, MD, MS, Stephenson Cancer Center
Advertisement
Latest Updated Articles
Rationale for Combination Therapy in Advanced ECPublished: February 4th 2021 | Updated:
GARNET Clinical Trial Regimen in Advanced DiseasePublished: February 4th 2021 | Updated:
Therapy Sequencing Through Multiple Lines of Therapy in ECPublished: February 4th 2021 | Updated:
Adjuvant Chemotherapy +/- Radiotherapy: Recent DataPublished: February 4th 2021 | Updated:
Safety/Efficacy Results From EC Cohort of KEYNOTE-146Published: February 4th 2021 | Updated:
Genomic Assessments for Metastatic DiseasePublished: January 29th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5












